Contact
Please use this form to send email to PR contact of this press release:
vTv Therapeutics Announces Licensing Agreement for Novel Nrf2 Activator to Anteris Bio
TO:
Please use this form to send email to PR contact of this press release:
vTv Therapeutics Announces Licensing Agreement for Novel Nrf2 Activator to Anteris Bio
TO: